Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

ALR Technologies (ALRT)

Add ALRT Price Alert      Hide Sticky   Hide Intro
Moderator: Sam'd'Mil, makinezmoney, knowmystuff, big green tractor, rhardy270, Pi_Sky2017
Search This Board: 
Last Post: 10/22/2017 5:57:48 PM - Followers: 181 - Board type: Free - Posts Today: 0





ALR Technologies, Inc. (OTCBB: ALRT) is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases.
ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website.
Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals.
Currently, the company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.

ALRT received FDA clearance for the HeC system in October, 2011.  Company CEO, Sidney Chan, commented, "We are pleased to reach this milestone and are
eager to introduce to market this cross-platform technology. The HeC System represents a breakthrough for clinician/patient communication to enhance disease
management and improve health outcomes. The System provides the potential to achieve significant savings to the US healthcare system through enhanced adherence to
care plans. In anticipation of the FDA clearance, we have been cultivating relationships with manufacturers of diabetes test supplies and insurance
companies to help facilitate a successful launch."

President and COO Lawrence Weinstein added, "Diabetes management represents the initial chronic illness application for HeC and we plan to
expand upon that platform in 2012. A first-to-market product, the HeC System bridges gaps in current remote monitoring systems in a manner that is
efficient, effective and affordable. We anticipate a strong demand based upon our present relationships with industry leaders. Given the flexibility of the HeC System,
the potential is enormous. This FDA clearance is a major stride in our commitment to building long-term shareholder value as there is a wide spectrum of chronic
diseases which the HeC platform can be deployed to improve outcomes and contain costs."





Sidney S. Chan, CEO and Chairman

Mr. Chan has been involved in managing ALR Technologies since August 1997. Since then, he has played a pivotal role in the evolution of ALR Technologies into a public company. Mr. Chan has been extensively involved in the company's finances and product development. 

Mr. Chan is an engineer who obtained his Bachelor of Engineering (Mining) degree with the distinction in Mineral Economics from McGill University in 1973.

Larry Weinstein, President and Chief Operating Officer

Mr. Weinstein joined ALRT in July 2010, bringing over 25 years of medical device development and management experience from organizations such as Cordis Corporation, DHD Healthcare and PARI Respiratory Equipment. 

Mr. Weinstein received a Bachelor of Science in Chemical Engineering degree from Rensselaer Polytechnic Institute. He earned both a Master of Science degree in Industrial Engineering and an MBA from the University of Miami.

William S. Smith, Director, Commercial Strategy and External Affairs

William S. Smith has worked at senior levels in the private sector and in government. He has more than a decade of experience in healthcare. He served as Managing Director at NSI, a Washington-based government affairs firm. His clients have included major pharmaceutical and biotechnology companies where Mr. Smith has provided strategic advice on government affairs challenges.

Mr. Smith spent ten years at Pfizer, Inc, where he was Vice President for U.S. Public Affairs and Policy. In that role, Smith was the lead advisor on U.S. policy issues to Pfizer's major commercial businesses in the United States. Smith also ran Pfizer's state government affairs group, one of the largest such groups in corporate America.

Mr. Smith previously worked in government where he was on the staff of two Governors in Massachusetts, was a leadership aide to the Republican Leadership in the U.S. House of Representatives, and was a senior aide in the White House Office of National Drug Control Policy under President George H.W. Bush.

Mr. Smith is a graduate of Georgetown University and has a Masters in Politics from the Catholic University of America.

Jerome P. Hickey, Director of Sales and Marketing

Mr. Hickey was most recently National Account Manager at Medicis Pharmaceutical Company, working with many of the largest healthcare payers in the U.S. Prior to Medicis, Mr. Hickey had extensive experience in sales at Pfizer, Inc., rising from a sales representative to assume such positions as Director of Managed Markets Training and Regional Director of Managed Markets for the New York region, one of Pfizer's most important sales regions. Mr. Hickey was responsible for delivering over 1.4 billion dollars in gross revenue at Pfizer.

Kent Stoneking, Pharm. D., CDE, Director, Diabetes Care Facilitation

Dr. Stoneking is a Certified Diabetes Educator (CDE) who has gained extensive, hands-on experience working with a network of internal medicine and family practice physicians to assist patients with diabetes education and self-management training. He received his Doctor of Pharmacy from the University of Tennessee and is an affiliate member of the American Diabetes Association and the American Pharmacists Association.  Dr. Stoneking is Chair of Pharmacy Practice at Union University School of Pharmacy, Jackson, Tennessee.

Dr. Alfonso Salas, Director

Dr. Salas graduated with distinction from Universidad Metroplitana of Barranquilla, Colombia in 1983 with a Doctor of Medicine degree. He began practicing in Santa Marta, Columbia in rural medical facilities and the opened a private practice in 1984. He then worked as a physician with a number of shipping companies and became Medical Director in the office of the Ministry of Social Security and Labor of Columbia in 1991 doing medical assessments for work related accidents. In 1993 Dr. Salas was appointed Director of a Medical Service Plan of Columbia and with a support staff of more than thirty people, maintained a caseload, provided assessment procedures and referral services to hospitals, clinics, and specialists and organized and monitored clinical trials and clinical research in the pharmaceutical and medical field. Since 1995 Dr. Salas has operated his own business in Vancouver, British Columbia, providing medical based consulting services for corporations with a focus on budgeting, research and medical services.

Kenneth Robulak, Director

From December 14, 1999 to January 31, 2001, Mr. Robulak was a member of the ALRT board of directors and from April 4, 2000 to January 31, 2001 Mr. Robulak was ALRT's chief financial officer, secretary, treasurer and vice president.  Mr. Robulak resigned as an officer and director on January 31, 2001. At the time of his resignation, Mr. Robulak did not have any disagreements with ALRT relating to our operations, policies, or practices. Since August 2005, Mr. Robulak has served as a Director of Belle Harbor Owners Association, a not for profit company in Clearwater Beach, Florida. Since July 2007, Mr. Robulak has worked as a marketing consultant to Teco Metal Products, LLC, a technology based manufacturing Company with operations in Dallas, Texas and Guadalajara, Mexico . Mr. Robulak earned a Bachelor of Commerce degree in finance and marketing and is a Fellow of the Institute of Canadian Bankers.


Diabetes information:

CDC Fact Sheet:

Additional Reading: 

One in 10 Adults to Have Diabetes by 2030 as Cases Surge 90%, Report Says (Bloomberg)
Diabetes forecast to hit one in 10 adults by 2030 (Reuters)
Diabetes News Highlights Global Pandemic and Millions of Dollars Wasted (MarketWatch)
Web Black Market in Diabetic Supplies Costs Government $200m (The Daily Beast)

(More to Come...)



February 04, 2013 - ALR Technologies Letter to Shareholders
January 28, 2013 - ALR Technologies Appoints Dr. Kent Stoneking as Director of Diabetes Care Facilitation
January 22, 2013 - ALR Technologies Releases Video on how ALRT Diabetes Care Facilitators Use the Health-e-Connect System (to Improve Outcomes and HEDIS Scores)
January 14, 2013 - ALR Technologies Releasing a Marketing Video with the Commercial Launch of the Health-e-Connect system for Diabetes Care
January 07, 2013 - ALR Technologies Inc. Announces Director of Sales and Marketing

News Archive:


Effect of Internet Therapeutic Intervention on A1C Levels in Patients With Type 2 Diabetes Treated With Insulin



A complete list of videos for viewing is located at:


Taglich Brothers:  PowerPoint format:


download the PDF file by clicking the image.



Outstanding Shares:  233,977,909
Float:  approximately 109,000,000
Insiders Holdings:  approximately 60%
(information as of Feb. 18, 2013, per Yahoo Finance)


ALR Technologies, Inc.
7400 Beaufont Springs Dr.   Suite 300
Richmond, VA     23225
Tel: 804-554-3500



Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALRT News: Current Report Filing (8-k) 10/18/2017 12:36:02 PM
ALRT News: Current Report Filing (8-k) 10/03/2017 02:17:00 PM
ALRT News: Current Report Filing (8-k) 09/22/2017 06:02:10 AM
#5574  Sticky Note Sidney's responses buzzabby 09/27/17 08:52:20 PM
#3763  Sticky Note First, we offered our Diabetes Management System, without GS1 09/21/17 11:16:23 PM
#3104  Sticky Note Sidney Chan emailed me. They plan to market Type0neg 09/20/17 04:52:47 PM
#2174  Sticky Note $ALRT tape-reading level-1 bid/ask price_&_size_w/Time+Sales. dazetrader 09/20/17 01:05:35 AM
#985  Sticky Note NEWS: Massive runner right now...... WOooooooooooooooooooo makinezmoney 09/19/17 10:05:12 AM
#6357   NEW - Details of the ALRT Diabetes Management PhenixBleu 10/22/17 05:57:48 PM
#6356   MODS - Please link Alert Technologies YouTube Channel PhenixBleu 10/22/17 05:55:15 PM
#6355   So did Cisco and many others. This buzzabby 10/22/17 02:16:13 PM
#6354   One good thing Apple started in a garage restripe 10/22/17 01:57:01 PM
#6353   Exactly GrandeS. It is obvious you have buzzabby 10/22/17 01:21:19 PM
#6352   Why not I love round numbers..2 million is Budman33 10/22/17 01:14:28 PM
#6351   They are not a husband and wife team. GrandeS 10/22/17 01:06:11 PM
#6350   I am not bothered by that. They buzzabby 10/22/17 01:03:37 PM
#6349   Yes I would like to go on heavy restripe 10/22/17 12:36:02 PM
#6348   Wow this is going to be huge. buzzabby 10/22/17 10:34:11 AM
#6347   Shares were reduced in March. I’ll go back and Neophius 10/22/17 09:51:37 AM
#6346   I’ll have to look into that, but I Neophius 10/22/17 09:09:15 AM
#6345   I don't see a filing to indicate an penguin007 10/22/17 07:56:06 AM
#6344   Yes you are correct, the A/S was increased penguin007 10/22/17 07:51:09 AM
#6343   New video just came out. Nan Doe 10/21/17 10:30:59 PM
#6342   I have 859,000 shares. Should I shoot for johnglenn 10/21/17 09:01:27 PM
#6341   $ALRT should see monster PPS gains over time. Werbe 10/21/17 01:41:06 PM
#6340   That’s a fantastic setup for insider sales next Neophius 10/21/17 09:03:53 AM
#6339   I believe you’re referring to the A/S, and Neophius 10/21/17 09:01:58 AM
#6338   Just a question...why is the increase in o/s penguin007 10/21/17 08:30:24 AM
#6337   But restripe 10/20/17 11:33:13 PM
#6336   Sounds good with this baby is paying all restripe 10/20/17 11:32:49 PM
#6335   Another red day. If they are serious care powerbattles 10/20/17 08:50:51 PM
#6334   I also expect we will see announcements on buzzabby 10/20/17 06:09:49 PM
#6333   Sidney's Response buzzabby 10/20/17 05:53:14 PM
#6332   I know part of the answer because I buzzabby 10/20/17 02:48:55 PM
#6331   Others (Buzz) may be able to answer better TheLastOneSitting 10/20/17 02:08:20 PM
#6330   Have been following the last few days and LaddyMan 10/20/17 01:39:01 PM
#6329   GrandeS 10/20/17 12:14:23 PM
#6327   I started buying ALRT several years ago. I've GrandeS 10/20/17 11:50:42 AM
#6325   LOL. The turnip truck left without me. No MickeyV 10/20/17 11:25:16 AM
#6322   What's your timeframe for such a lofty promise? Neophius 10/20/17 11:15:42 AM
#6321   I'll take a 10X any day! MickeyV 10/20/17 11:14:56 AM
#6320   you should feel good. You'll still make GrandeS 10/20/17 11:12:26 AM
#6319   I wish I had some of that 0016. MickeyV 10/20/17 11:04:24 AM
#6318   yes, I did buy some at .0016 and GrandeS 10/20/17 09:50:48 AM
#6317   Your post raises a question that I've had: OBE 10/20/17 09:39:27 AM
#6316   I think the float is even less than GrandeS 10/20/17 09:10:00 AM
#6315   I don't know how accurate they are on buzzabby 10/20/17 09:05:22 AM
#6314   Great article. It's about time this company is GrandeS 10/20/17 09:04:53 AM
#6313   I started buying ALRT several years ago. GrandeS 10/20/17 09:01:34 AM
#6312   Got-my .036s...just-another-10k. I'll-look-back-on-the-buy and think "WOW! I-bo OBE 10/20/17 08:32:03 AM
#6311   Yes, nice article. Curious. Since the MickeyV 10/20/17 08:03:03 AM
#6310   Nice Article DD buzzabby 10/19/17 11:43:14 PM
#6309   I've accumulated 100K at .057, something I rarely MickeyV 10/19/17 04:26:20 PM
#6308   I would expect news within a few weeks GrandeS 10/19/17 03:34:54 PM
#6307   Easy buy and hold TheLastOneSitting 10/19/17 03:16:41 PM
#6306   Thanks ONCO I can't reply to PVT buzzabby 10/19/17 03:14:28 PM
#6305   I think in the next 3-4 months there buzzabby 10/19/17 02:46:43 PM
#6304   Seems like more news will be coming. Below SuperAm 10/19/17 02:21:42 PM